Ngā hua rapu kaituhi

1

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway mā Todd M. Morgan, Theodore D. Koreckij, Eva Corey

I whakaputaina 2009

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

A ribonucleoprotein octamer for targeted siRNA delivery mā Wanyi Tai, Junwei Li, Eva Corey, Xiaohu Gao

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression mā KD Brubaker, Vessella Rl, LD True, Regi Thomas, Eva Corey

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment mā Kristen D. Brubaker, Lisha G. Brown, Robert L. Vessella, Eva Corey

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Bone morphogenetic protein signaling in prostate cancer cell lines mā Kristen D. Brubaker, Eva Corey, Lisha G. Brown, R L Vessella

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration mā Alvin Y. Liu, Eva Corey, Franck Bladou, Paul H. Lange, Robert L. Vessella

I whakaputaina 1996

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer mā Bruce Montgomery, Peter S. Nelson, Robert L. Vessella, T F Kalhorn, David L. Hess, Eva Corey

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Bone Morphogenetic Protein 7 Is Expressed in Prostate Cancer Metastases and Its Effects on Prostate Tumor Cells Depend on Cell Phenotype and the Tumor Microenvironment mā Colm Morrissey, Lisha G. Brown, Tiffany E.M. Pitts, Robert L. Vessella, Eva Corey

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis mā Seiji Arai, Oliver Jonas, Matthew A. Whitman, Eva Corey, Steven P. Balk, Sen Chen

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Lineage relationship between prostate adenocarcinoma and small cell carcinoma mā Adelle D. Kanan, Eva Corey, Ricardo Z. N. Vêncio, Arjun Ishwar, Alvin Y. Liu

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis mā Siyuan Cheng, Lin Li, Yunshin Yeh, Yingli Shi, Omar E. Franco, Eva Corey, Xiuping Yu

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis mā Theodore D. Koreckij, Holly M. Nguyen, Lisha G. Brown, Evan Y. Yu, R L Vessella, Eva Corey

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Nemo‐like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells mā Katayoon H. Emami, Lisha G. Brown, Tiffany E.M. Pitts, Xizhang Sun, Robert L. Vessella, Eva Corey

I whakaputaina 2009

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid mā Todd M. Morgan, Tiffany E.M. Pitts, Ted S. Gross, Sandra L. Poliachik, Robert L. Vessella, Eva Corey

I whakaputaina 2008

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer mā Philip Martin, J-J Yin, Victoria Seng, Órla Casey, Eva Corey, Colm Morrissey, Rebecca Simpson, Kathleen Kelly

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Radium-223 mechanism of action: implications for use in treatment combinations mā Michael J. Morris, Eva Corey, Theresa A. Guise, James L. Gulley, William Kevin Kelly, David I. Quinn, Arne Scholz, George Sgouros

I whakaputaina 2019

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer mā Dali Zheng, Keith F. Decker, Tianhua Zhou, Jianquan Chen, Zongtai Qi, Kathryn Jacobs, Katherine N. Weilbaecher, Eva Corey, Fanxin Long, Jia Li

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer mā Ali Ghoochani, En‐Chi Hsu, Merve Aslan, Meghan A. Rice, Holly M. Nguyen, James D. Brooks, Eva Corey, Ramasamy Paulmurugan, Tanya Stoyanova

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: Results from the University of Washin... mā Colm Morrissey, Martine P. Roudier, Alex Dowell, Lawrence D. True, Melanie Ketchanji, Christopher Welty, Eva Corey, Paul H. Lange, Celestia S. Higano, Robert L. Vessella

I whakaputaina 2012

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer mā Maria Thadani‐Mulero, Luigi Portella, Shihua Sun, Matthew Sung, Alexandre Matov, Robert L. Vessella, Eva Corey, David M. Nanus, Stephen R. Plymate, Paraskevi Giannakakou

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Eva Corey

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway mā Todd M. Morgan, Theodore D. Koreckij, Eva Corey

A ribonucleoprotein octamer for targeted siRNA delivery mā Wanyi Tai, Junwei Li, Eva Corey, Xiaohu Gao

Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression mā KD Brubaker, Vessella Rl, LD True, Regi Thomas, Eva Corey

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment mā Kristen D. Brubaker, Lisha G. Brown, Robert L. Vessella, Eva Corey

Bone morphogenetic protein signaling in prostate cancer cell lines mā Kristen D. Brubaker, Eva Corey, Lisha G. Brown, R L Vessella

Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration mā Alvin Y. Liu, Eva Corey, Franck Bladou, Paul H. Lange, Robert L. Vessella

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer mā Bruce Montgomery, Peter S. Nelson, Robert L. Vessella, T F Kalhorn, David L. Hess, Eva Corey

Bone Morphogenetic Protein 7 Is Expressed in Prostate Cancer Metastases and Its Effects on Prostate Tumor Cells Depend on Cell Phenotype and the Tumor Microenvironment mā Colm Morrissey, Lisha G. Brown, Tiffany E.M. Pitts, Robert L. Vessella, Eva Corey

Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis mā Seiji Arai, Oliver Jonas, Matthew A. Whitman, Eva Corey, Steven P. Balk, Sen Chen

Lineage relationship between prostate adenocarcinoma and small cell carcinoma mā Adelle D. Kanan, Eva Corey, Ricardo Z. N. Vêncio, Arjun Ishwar, Alvin Y. Liu

Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis mā Siyuan Cheng, Lin Li, Yunshin Yeh, Yingli Shi, Omar E. Franco, Eva Corey, Xiuping Yu

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis mā Theodore D. Koreckij, Holly M. Nguyen, Lisha G. Brown, Evan Y. Yu, R L Vessella, Eva Corey

Nemo‐like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells mā Katayoon H. Emami, Lisha G. Brown, Tiffany E.M. Pitts, Xizhang Sun, Robert L. Vessella, Eva Corey

RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid mā Todd M. Morgan, Tiffany E.M. Pitts, Ted S. Gross, Sandra L. Poliachik, Robert L. Vessella, Eva Corey

Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer mā Philip Martin, J-J Yin, Victoria Seng, Órla Casey, Eva Corey, Colm Morrissey, Rebecca Simpson, Kathleen Kelly

Radium-223 mechanism of action: implications for use in treatment combinations mā Michael J. Morris, Eva Corey, Theresa A. Guise, James L. Gulley, William Kevin Kelly, David I. Quinn, Arne Scholz, George Sgouros

Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer mā Dali Zheng, Keith F. Decker, Tianhua Zhou, Jianquan Chen, Zongtai Qi, Kathryn Jacobs, Katherine N. Weilbaecher, Eva Corey, Fanxin Long, Jia Li

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer mā Ali Ghoochani, En‐Chi Hsu, Merve Aslan, Meghan A. Rice, Holly M. Nguyen, James D. Brooks, Eva Corey, Ramasamy Paulmurugan, Tanya Stoyanova

Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer mā Maria Thadani‐Mulero, Luigi Portella, Shihua Sun, Matthew Sung, Alexandre Matov, Robert L. Vessella, Eva Corey, David M. Nanus, Stephen R. Plymate, Paraskevi Giannakakou

Ngā utauta rapu:

Ngā marau whai pānga